Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves as Vice President on the Executive Board of PhactMI.

Elizabeth Brown is a Senior Director and TA Lead of Oncology Medical Writing at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years. First as a laboratory scientist, then as a clinical researcher, and currently as a medical writer. Elizabeth brings a project and people management focus to her role as a regulatory medical writer and department leader. With this focus, she has developed a passion for developing people, advising teams and providing strategic guidance how to deliver efficient, effective, and high-quality documents.

Elizabeth C. Froom, PharmD, is a Senior Director in the Medical Writing and Healthcare Communications team at Evidera. She has over 20 years of medical information and writing experience. In her role she provides strategic direction and oversight to a global team of medical writers who deliver medical information services including standard response documents, custom responses, Academy of Managed Care Pharmacy (AMCP) dossiers, infographics, and promotional review. Her educational background includes a BS in pharmacy and a PharmD from the University of South Carolina College of Pharmacy.

Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

As ever-questioning medical communication professional with an international reputation, I have been communicating science to children, grandmothers, business professionals, government agencies, and scientific experts for more than 15 years. My technical areas of expertise span across infectious disease, immunology, oncology, and vaccines and include content deliverables at all stages within a product's lifecycle.

Brooke has worked within the pharmaceutical industry for the past 9 years starting as an MSL and progressing through escalating field and home office leadership roles. Brooke has led Medical engagement strategies across 15 launches for both small and large molecules and across multiple therapeutic areas. Brooke is currently the Head of Medical Affairs Strategy and Operations for GSK

Dr. Nimita Limaye leads R&D Strategy and Technology at IDC Health Insights, providing research-based advisory and consulting services on the Life Sciences industry. She represents Healthcare and life science on IDC's AI Council. She is an executive business leader with more than two decades of life sciences leadership experience in the pharma/CRO/tech consulting industry. She focuses on the role of data and technology in transforming drug development, RWD, synthetic data and analyzing and predicting evolving trends in the life sciences industry. Nimita was the chair of the SCDM board, chaired several conferences roundtables, given keynote talks, participated in fireside chats, and authored close to a 100 thought leadership papers.

Fabiana Ebihara has over 18 years of extensive experience in the field of medical writing, with a particular focus on leadership and regulatory affairs. Throughout her career, Fabiana has held several key leadership positions at Parexel International, where she has played a pivotal role in managing partnerships with large pharmaceutical companies. She provided financial and operational oversight and led projects covering a range of therapeutic areas. Fabiana has successfully implemented process improvements, mentored teams, and contributed to business development efforts.

Richard Swank is the former head of US Field Medical and Global Field Medical Excellence at Amgen and Founder of Scientific Engagement LLC. He has spent most of his career building medical capabilities in Medical Affairs, including building and managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He has a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for the last 3 years.

Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 22 years in the biopharma industry. His experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, omnichannel communications, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.

Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information. She received both a BS in Pharmacy and a PharmD from Rutgers and completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service. For 25 years she was the Director of Drug Information Services at Robert Wood Johnson University Hospital and a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers.

In her current role, she provides strategic leadership and oversight for activities related to Medical Information and Medical Information Digital solutions. She began her career as a community pharmacist, before joining the Pharmaceutical Advertising Advisory Board (PAAB) as an Assistant Commissioner. She joined Lilly, 21 years ago, first supporting Medical Information before holding various roles in Legal, Sales, Compliance and Medical Affairs. Joanna obtained her B.Sc. in pharmacy from the University of Toronto and her MBA from the Schulich School of Business. Joanna is also a board member of the Pharmacovigilance and Medical Information Network (PVN-MI) Canada.

John Jones is an experienced IT Strategist focused on developing innovative technology solutions for unmet business needs in Life Sciences. John is currently the Founder and CEO of Entitech Solutions, a Life Sciences focused IT Software and Consulting firm. Prior to starting his company, John led Quintiles’ IT Consulting Division from 2010 – 2015 focusing on IT Advisory and Implementation services in Life Sciences. John has more than 20 years experience in developing and delivering IT Solutions for various companies, and has extensive experience in the clinical, regulatory, and commercial areas.

Tamei Elliott, MS, serves as the Associate Director of Scientific Programs for the Americas region at DIA. In this pivotal role, she is responsible for identifying and prioritizing content areas and topics crucial to DIA constituents. Tamei assesses the implications of significant regulatory and health policy changes, seamlessly integrating relevant content into the development and advancement of DIA conferences and courses. Her responsibilities extend to overseeing content development and strategy within the Americas region.

Kari is Vice President and Chief Compliance Officer for Cytokinetics, Inc., where she provides executive management, direction, and oversight for all aspects of the compliance program, policies, monitoring, training, privacy, and brand-legal advisory. Previously, Kari was the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma, Inc., and a Senior Director/Senior Compliance Counsel at Jazz Pharmaceuticals. She has extensive experience in providing legal and compliance advice on sales, marketing, promotional and medical materials review, Medical Affairs, managed care, commercial compliance, as well as U.S. Sunshine / aggregate spend and compliance operations.

Patricia Bourne, PharmD, Senior Director, Medical Sciences at Cytokinetics has over 25 years of industry experience leading both therapeutic and managed care field teams. At Cytokinetics, Patricia is responsible for leading the development of medical strategies that support market access and driving field tactics with a goal of patient access and improving patient outcomes. She has owned a retail pharmacy, worked as a clinical pharmacist and Director of Pharmacy Services at a managed care organization giving additional perspectives in healthcare. Before joining Cytokinetics, she led the Medical Affairs' market access strategies at Gilead Sciences across a range of therapeutic areas and population-based decision maker teams.

Lisa Chamberlain James is a Senior Partner and Chief Executive Officer of Trilogy Writing & Consulting. Aside from management activities, she also leads client projects, with extensive experience in a variety of documents and a special interest in drug safety and patient information. After receiving her Ph.D. in Pathology, Lisa began her medical writing career in Cambridge in 2000. Since then, she has been heavily involved in the EMWA on the Education Committee and as a workshop leader, is a visiting lecturer for King’s College London, initiated and chaired the EMWA PV and Communicating with the Public SIGs, is chair of the Geoff Hall Scholarship Committee, section editor for Medical Writing, and a Fellow of the Royal Society of Medicine.

As the Director of Leadership Excellence, Purvi builds leadership capability within medical and commercial teams at EMD Serono, a critical investment in enhancing current and future leaders’ skills, abilities and confidence. Purvi brings 20+ years’ experience, most recently 7 years as a Senior Executive Consultant at the FDA, helping the agency develop their leadership development strategy and approach. As an ICF-certified coach, Purvi has worked with leaders at all levels, helping them gain important insights and empowering them to operationalize who they want to be as leaders. Purvi holds a BS in Health Science from the Univ. of Texas HSC, a MEd in Public Health Ed from Univ. of Houston, and a MPA from George Mason Univ.

After receiving her PhD in Developmental Neurobiology, Julia became a medical writer in 1997. In 2002, she co-founded Trilogy Writing & Consulting, a company specialized in medical writing of regulatory documentation. As a Senior Partner she continues to bring her enthusiasm and experience to client projects. She has twice been President of the European Medical Writers Association (EMWA), is an experienced trainer of medical writers, and runs workshops for EMWA, AMWA, DIA, and pharma companies around the world.

Ritama Gupta Dempsey is an Associate Director of Disclosure Medical Writing at Merck & Co., Inc. As the operational head for clinical trial disclosures, she is dedicated to establishing long-term strategies within the evolving transparency landscape. Ritama is passionate about developing talent and building cross-functional relationships with diverse stakeholders to enhance disclosure initiatives. She has a background in academic scientific research and holds a PhD in Immunology and Microbial Pathogenesis from Weill Cornell Graduate School of Medical Sciences.

Valerie Huh brings over 20 years of expertise in the pharmaceutical, healthcare, and education sectors. She holds a Pharm.D and an MBA, and she is passionate about leveraging advanced technology and new ways of working to improve operational efficiency. In her current role, she is dedicated to enhancing customer journeys by innovating processes within medical information contact centers.

Jones is an Associate Partner at ZS Associates, a Global Healthcare Management Consulting Firm and leads the Medical Omnichannel / Digital Transformation Domain. He has over a decade of experience and worked with 20+ pharma organizations across omnichannel / digital domains spanning strategy, technology and analytics. He has supported organizations in areas like digital and omnichannel strategy & roadmapping, technology ecosystems, digital blueprint and activation, engagement process redesign, omnichannel orchestration, digital analytics and reporting Jones holds an MBA from Washington University in St. Louis and a Bachelors Degree in Electronics and Communication Engineering from Cochin University, India

Ana Magalhaes is a Senior Manager of Medical Writing at Precision for Medicine with over a decade of clinical trial experience, specializing in documentation and regulatory compliance. Leveraging an academic foundation in clinical research, health sciences, and statistics, Ana optimizes clinical trial processes through the development of regulatory documentation, ensuring consistency and efficiencies from study initiation to completion. Ana has a proven track record in translating complex scientific data into clear and concise protocols that are tailored to address the unique challenges of oncology and rare indications, meet regulatory requirements, and facilitate successful study execution.

Gary Messplay is a Partner in the Washington, D.C., office of King & Spalding. He represents life sciences clients before the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA), and other federal and state agencies. Mr. Messplay's practice includes regulatory and administrative law matters, clinical trials, criminal and civil enforcement matters, healthcare compliance, internal investigations, litigation, liability counseling, and transactional work related to pharmaceutical products. He has written extensively about pharmaceutical compliance issues and is a frequent speaker on regulatory and compliance matters. He is a member of the Food and Drug Law Institute, where he serves on FDLI’s Editorial Advisory Board.

Dr. Jessica Steier is a public health scientist and health services researcher with expertise in health policy evaluation. She is the CEO of Vital Statistics Consulting, a data science consultancy, and founder and host of Unbiased Science, a science communication brand. She is also the executive director of The Science Literacy Lab, a non-profit organization aimed at improving health and science literacy and empowering people to make informed decisions that impact their well-being. Dr. Steier received her Master of Public Health (Evaluative Sciences) at SUNY-Stony Brook University and her Doctor of Public Health degree from the Graduate Center at the City University of New York (CUNY).

Dr. Robin Winter-Sperry is currently the Field Medical Excellence, International / Oncology Lead at Pfizer. With roles of increasing responsibility, she was the Global MSL Lead at Ipsen. Prior to joining Ipsen, she was Head, Global Field Based Medical Excellence and Insights at Sanofi Genzyme after joining as VP, Strategy, MS. With extensive consulting experience as President of Scientific Advantage, she’s been instrumental in Medical Affairs strategy, operations including mergers, transitions and organizational design. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry, responsible for creating and developing many of the industry’s leading Medical Affairs and Field Medical teams.

Pooja Banerjee, with 18+ years of experience, is a leader in medical communications holding a masters in Pharmaceutical Chemistry and a Postgraduate Diploma in Health Communications. She specializes in strategic communication for the Pharma and Biotech industries and has successfully managed publications, medico-marketing, and medical education projects. Her expertise includes public health campaigns, RWE projects, advisory boards, and developing consensus statements and clinical guidelines. Pooja is also a thought leader, active mentor, and faculty member driving innovation in healthcare communication.

Dave brings over 14 years of Medical Information Contact Center Management and Operations experience. A licensed Registered Nurse, he began his career as a front-line Medical Information Specialist and has continually advanced into roles of increasing responsibility within the Medical Affairs industry. He is currently the Senior Director, Medical Information Service Delivery (Operations and Account Management) at ProPharma. Dave's passion for the patient and HCP experience is evident in his approach to staff selection, employee development and operational excellence of his teams.

Jeff is a senior HEOR leader, with a focus on generating and communicating value evidence for payor audiences. Jeff led the Global Health Outcomes and Payer MSL teams at Allergan after several years as International Director of Pharmacoeconomics at Glaxo. Jeff is an ACCP Fellow, led development of ACCP's pharmacoeconomics fellowship training programs, and was Chair of the AMCP Format Executive Committee, where he led development of the AMCP Format 4.0. He also actively supported AMCP's advocacy efforts around preapproval information exchange in Congress. At Lumanity, Jeff is the US Region Lead within the Value Demonstration Practice, advising clients across the spectrum of value evidence generation and communication activities.

Dr. Oladayo Oyelola is Senior Director and Head, Clinical Trial Information Disclosure at Daiichi Sankyo. He oversees corporate clinical trial transparency/data sharing strategies and compliance activities; coordinates internal disclosure operations’ training, process improvements and trial transparency policy intelligence. He holds a PhD in Clinical Chemistry from Obafemi Awolowo Univ. Ile-Ife, Nigeria, 1990 and received The Rockefeller Foundation Postdoctoral Fellowship, 1991 and National Mentor Role Model Award of Minority Access Inc/Office of Minority Health, NIH, 2001. Dr. Oyelola has over 35 years’ experience in biomedical R&D, and certifications by National Registry of Certified Chemists and American Society for Clinical Pathologist

Vladimir Penkrat is AVP of Regulatory Affairs at Indegene. With an MBA in International Business, Vladimir has provided strategic leadership throughout his career across R&D functional areas including clinical development, biometrics, biostatistics, medical writing, pharmacovigilance, and regulatory affairs. Over the past three decades Vladimir has experience in top pharmaceutical, biotech startups, CROs, and consulting firms. Vladimir's leadership has enabled clients’ businesses to prepared and adapt to the evolving digital landscape and prepare for changes. As a business leader he has scaled business operations greater than 500 FTE in size globally to deliver services across the R&D landscape.

Mary is the Regional North America Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.

I have 18 years experience in healthcare data and analytics, working to generate intelligence across providers, payers and pharma, always with the goal of driving better health outcomes. In my current role at Sorcero, I help Med Affairs teams around the world utilize AI to optimize engagement and drive better care for patients. At GSK, I was Director of Data Science, US Med Affairs. While there, I built a Center of Excellence for Data Science to develop and apply ML and NLP capabilities to accelerate the very manual process of mining unstructured data for insights on customers and patients. As Head of Product at Stratifyd, my remit is to grow our text analytics platform to meet market needs, with a key focus on Medical Affairs.

Samantha Winders is a Regulatory Medical Writer at Aroga Biosciences, dedicated to advancing symptom management and enhancing scientific communication. She holds a PhD in Nursing Science from the University of Florida and completed a postdoctoral fellowship at the University of Washington. During her fellowship, her research focused on self-management strategies for individuals with Inflammatory Bowel Disease (IBD), with an emphasis on factors affecting sleep and overall well-being in this population.

> 10 years experience of writing in the pharmaceutical industry. Before joining PAREXEL Medical Writing Services in Jan 2003 he was the Deputy Executive Editor for IMS Health’s R&D Focus. James completed a PhD in apoptosis, and then did a Post-Doc in the role of apoptosis in endometriosis.

Michelle is currently the Global Medical Information Lead at Idorsia Pharmaceuticals Ltd. She has worked in industry Globally for over 15 years in roles including: Medical Device Sales, Med Info, Pharmacovigilance and Medical Affairs for Ethicon Endosurgery (a J&J Company), Eli Lilly, Pfizer, Amgen, Shire and Biogen. Michelle is very passionate about Med Info & Med Affairs and is highly motivated by innovative, customer centric ways to support healthcare and non-healthcare professionals around the world to ensure the safe and effective use of medicines.

Ann joined Roche in 2008 and became the Field Director of the Ophthalmology Medical Science Liaisons in 2020. Her first leadership role was in 2017 as Associate Director of the Surgical Devices Liaison Team after the Roche acquisition of Forsight Vision4. The team expanded from 5 to 12 and completed Phase II and III trials for the Port Delivery System with ranibizumab, Genentech’s first surgically implanted device. Ann established the team's infrastructure, including Onboarding and training, case support documentation, and KPIs. Before this, she served as an MSL for the CV/Metabolism and Ophthalmology teams and worked in Medical Communications at Janssen and as an MSL at Bristol-Myers Squibb.

Jeanette Towles, MA, RAC, is the CEO of Synterex, Inc., a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Prior to that, she held in-house consulting and FTE medical writing and clinical science positions at both small- and large-size companies, including managing a group of programmers and vendors working on automated documents, with cumulative industry experience of nearly 20 years. She lives in the Boston area with her husband, 2 children, and dog.

Lauren Tulloch is Vice President & Managing Director at CCC. In that role, she is responsible for the Corporate Business Unit which includes copyright licenses, the RightFind product suite, and managed knowledge services. Prior, Tulloch held several product management leadership roles in the organization. Before joining CCC, she served as a group publisher at a healthcare education & training company. Tulloch began her career as a newspaper reporter and editor. She holds a Bachelor’s degree in journalism and political science from Boston University.

Simon Johns has over 25 years of experience supporting global pharmaceutical customer projects. As Director of Medical Information (MI) and Marketed Product Safety at IQVIA, he manages global MI projects focused on process optimization and technology enablement to drive enhanced efficiency and customer engagement. Simon is a member of the European DIA Medical Information and Communications Training Team, advising pharmaceutical companies on best industry practices, innovation and automation. He speaks regularly on topics ranging from combined human and AI conversational agent models for MI to the benefits and increased value of integrating MI and pharmacovigilance.